A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity.
McCafferty S, Haque AKMA, Vandierendonck A, Weidensee B, Plovyt M, Stuchlíková M, François N, Valembois S, Heyndrickx L, Michiels J, Ariën KK, Vandekerckhove L, Abdelnabi R, Foo CS, Neyts J, Sahu I, Sanders NN.
McCafferty S, et al. Among authors: michiels j.
Mol Ther. 2022 Sep 7;30(9):2968-2983. doi: 10.1016/j.ymthe.2022.04.014. Epub 2022 Apr 20.
Mol Ther. 2022.
PMID: 35450821
Free PMC article.